The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

7 Dec 2010 08:19

RNS Number : 4898X
China Growth Opportunities Ltd
07 December 2010
 



CHINA GROWTH OPPORTUNITIES LIMITED

RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2010

 

KEY POINTS

 

·; Net assets at 30 September 2010 of £5.7 million (30 September 2009: £14.4 million, 31 March 2010: £6.3 million).

·; Net assets per share at 31 March 2010 of 11.41p (30 September 2009: 28.77p; 31 March 2010: 12.52p).

·; Extension of Investment Policy to sell investments by 30 September 2011.

 

For further information please visit www.chinagrowthopportunities.com or contact:

 

Rhys Davies

Chairman

Tel: +41 (0) 79 620 0215

James Maxwell

Singer Capital Markets Limited

Tel: +44 20 3205 7623

Elysium Fund Management Limited

PO Box 650

No. 1 Le Truchot

St Peter Port

Guernsey

GY1 3JX

 

Tel: +44 1481 810 100

Fax: +44 1481 810 120

e-mail: Elysium@elysiumfundman.com

 

 

CHAIRMAN'S STATEMENT

 

I am pleased to have the opportunity to present the half-yearly results of China Growth Opportunities Limited (the "Company") for the six-month period ended 30 September 2010.

 

Results

During the six months ended 30 September 2010, the Company was successful in finding a buyer for Dalian Business Institute. Finding buyers for certain of the remaining investments is challenging but I believe that the Company is on course to sell the remaining investments in the portfolio by 30 September 2011 as per the new Investing Policy (see below).

 

The net assets of the Company at 30 September 2010 were £5.7 million, a decrease of £0.6 million from 31 March 2010, largely attributable to the decrease in valuations at the period end.

 

The Company made a net loss for the period of £0.6 million (1.11p per Ordinary Share) (30 September 2009: loss of £2.1 million, 31 March 2010: loss of £9.3 million).

 

Share Price

The share price dropped during the period by 28% from the 31 March 2010 price of 15.25p to 11.00p per Ordinary Share at 30 September 2010.

 

Investing Policy

Following the Annual General Meeting held on 14 September 2010, the Investing Policy of the Company was amended to be: "The Investing Policy of the Company is to manage the sale of the Company's investment portfolio and to maximise the return of invested capital to shareholders during the period ending on 30 September 2011."

 

Return of Capital

The Board continues to investigate every avenue to find purchasers for the remaining investments held by the Company and is confident that, in line with the new investing policy, purchasers will be found and further returns of capital will be made before 30 September 2011.

 

Investments

At 30 September 2010, the Company's main investment was a 14.64% holding, valued at £4.2 million, in China Metal Packaging Group Company Limited. Brett Miller was appointed to the board of China Metal Packaging Group Company Limited as a non-executive director in July 2009. The valuation, based on a discounted cash flow calculation, has increased by 3.7% since 31 March 2010 and reflects the value at which the Board believes the investment could have been exchanged between knowledgeable, willing parties in an arm's length transaction at the reporting date (so called "fair value").

 

The valuation of China CDM Exchange Centre Limited ("China CDM") fell by 32% in the period under review as we value it on an NAV basis, using a 75% discount to its AIM listed peer group of environmental investment companies. The discount used has increased from 50% at 31 March 2010 to 75% at 30 September 2010. Therefore, while the peer group traded at a 29% discount to NAV on 30 September 2010, we valued China CDM at an 82% discount to its stated NAV at 30 June 2010. During the period ended 30 September 2010, the Company sold 5,000 shares in China CDM for a total of £2,000, reducing the Company's holding in the investment to 8.23%. Following the period end, a further 257,500 shares in China CDM were sold for £14,500. We have found that there is a significant lack of liquidity in the market for the shares.

 

On 13 July 2010, the Company sold its entire holding in Dalian Business Institute for a total of $US10,000. China Real Estate Services was liquidated during the period. No funds were received by the Company as a result of the liquidation.

 

In the 31 March 2010 Annual Report and Financial Statements of the Company, we announced that the Company had agreed to sell its entire holding in the Wan Wei Oil and Gas Technology Group for a total of US$750,000, which was due in three equal instalments in September 2010, December 2010 and March 2010. The Company has not received the first instalment and it has become apparent that this sale will not now proceed.

 

At 30 September 2010, the Company had four remaining investments in its portfolio, valued at £4.7 million.

 

Outlook

The Board is optimistic that it will achieve the targets outlined in the Investing Policy and maximise the return to shareholders by negotiating the best possible value for the sale of the remaining investments.

 

Respectfully yours

 

R Davies

7 December 2010

 

 

CONDENSED HALF-YEARLY STATEMENT OF COMPREHENSIVE INCOME

 

for the six months ended 30 September 2010

 

 

1 April 2010 to

30 September 2010

1 April 2009 to

30 September 2009

1 April 2009 to

31 March 2010

(unaudited)

(unaudited)

(audited)

£'000

£'000

£'000

Investment gains and losses

Net unrealised change in fair value of investments

4,180

10,217

3,412

Realised loss from sale of investments

(4,535)

(11,308)

(11,303)

------------

------------

------------

Total investment losses

(355)

(1,091)

(7,891)

Income

Other income

1

6

7

------------

------------

------------

Total income

1

6

7

Expenses

Directors' remuneration

(69)

(89)

(179)

Administration fees

(63)

(108)

(170)

Other expenses

(69)

(271)

(395)

Investment Consultant's fee

-

(120)

(140)

------------

------------

------------

Total expenses

(201)

(588)

(884)

Loss on foreign currency exchange

-

(463)

(491)

------------

------------

------------

Loss for the period/year

(555)

(2,136)

(9,259)

Other comprehensive loss

Foreign currency translation differences

-

(1)

(2)

------------

------------

------------

Total other comprehensive loss

-

(1)

(2)

------------

------------

------------

Total comprehensive loss for the period/year

(555)

(2,137)

(9,261)

------------

------------

------------

Loss per share - basic and diluted

(1.11)p

(4.27)p

(18.52)p

 

 

 

CONDENSED STATEMENT OF FINANCIAL POSITION

as at 30 September 2010

30 September 2010

30 September 2009

31 March 2010

(unaudited)

(unaudited)

(audited)

£'000

£'000

£'000

Non-current assets

Investments designated at fair value through profit or loss

4,722

11,953

5,146

----------

----------

----------

Current assets

Other receivables

9

635

13

Cash and cash equivalents

1,057

1,875

1,212

----------

----------

----------

1,066

2,510

1,225

----------

----------

----------

Total assets

5,788

14,463

6,371

----------

----------

----------

Current liabilities

Payables and accruals

(82)

(78)

(110)

----------

----------

----------

Net assets

5,706

14,385

6,261

----------

----------

----------

Capital and reserves attributable to equity

holders of the Company

Share capital

500

500

500

Other reserve

2,293

2,293

2,293

Distributable reserves

2,913

11,591

3,468

Foreign exchange translation reserve

-

1

-

----------

----------

----------

Total equity shareholders' funds

5,706

14,385

6,261

----------

----------

----------

Net Asset Value per Ordinary Share - basic and diluted

11.41p

28.77p

12.52p

 

CONDENSED HALF-YEARLY STATEMENT OF CHANGES IN EQUITY

for the six months ended 30 September 2010 (unaudited)

 

 

Share capital

Other reserve

Distributable reserves

Foreign exchange translation reserve

 

Total

£'000

£'000

£'000

£'000

£'000

Balance at 31 March 2010

500

2,293

3,468

-

6,261

Total comprehensive income for the period

Loss for the period

-

-

(555)

-

(555)

----------

----------

----------

----------

----------

Balance at 30 September 2010

500

2,293

2,913

-

5,706

----------

----------

----------

----------

----------

 

for the six months ended 30 September 2009 (unaudited)

 

 

Share capital

Other reserve

Distributable reserves

Foreign exchange translation reserve

 

Total

£'000

£'000

£'000

£'000

£'000

Balance at 31 March 2009

500

2,293

22,727

2

25,522

Return of Capital

-

-

(9,000)

-

(9,000)

Total comprehensive loss for the period

Loss for the period

-

-

(2.136)

-

(2,136)

Other comprehensive loss for the period

-

-

-

(1)

(1)

----------

----------

----------

----------

----------

Balance at 30 September 2009

500

2,293

11,591

1

14,385

----------

----------

----------

----------

----------

 

for the year ended 31 March 2010 (audited)

 

 

Share capital

Other reserve

Distributable reserves

Foreign exchange translation reserve

 

Total

£'000

£'000

£'000

£'000

£'000

Balance at 31 March 2009

500

2,293

22,727

2

25,522

Return of Capital

-

-

(10,000)

-

(10,000)

Total comprehensive loss for the year

Loss for the year

-

-

(9,259)

-

(9,259)

Other comprehensive loss for the year

-

-

-

(2)

(2)

----------

----------

----------

----------

----------

Balance at 31 March 2010

500

2,293

3,468

-

6,261

----------

----------

----------

----------

----------

 

CONDENSED HALF-YEARLY STATEMENT OF CASH FLOWS

for the six months ended 30 September 2010

1 April 2010 to

30 September 2010

1 April 2009 to

30 September 2009

1 April 2009 to

31 March 2010

(unaudited)

(unaudited)

(audited)

£'000

£'000

£'000

Cash flows from operating activities

Other income received

1

6

8

Administration fees paid

(62)

(138)

(170)

Directors' remuneration paid

(88)

(86)

(164)

Audit fees paid

(23)

(25)

(66)

Other expenses paid

(52)

(246)

(359)

Investment Consultant's fees paid

-

(220)

(220)

----------

----------

----------

Net cash outflow from operating activities

(224)

(709)

(971)

Cash flows from investing activities

Sale of fair value through profit or loss investments

69

6,930

7,569

----------

----------

----------

Net cash inflow from investing activities

69

6,930

7,569

----------

----------

----------

Cash flow from financing activities

Return of capital

-

(9,000)

(10,000)

----------

----------

----------

Net cash outflow from investing activities

-

(9,000)

(10,000)

----------

----------

----------

----------

----------

----------

Decrease in cash and cash equivalents

(155)

(2,779)

(3,402)

----------

----------

----------

Cash and cash equivalents brought forward

1,212

4,930

4,930

Decrease in cash and cash equivalents

(155)

(2,779)

(3,402)

Foreign exchange movement

-

(276)

(316)

----------

----------

----------

Cash and cash equivalents carried forward

1,057

1,875

1,212

----------

----------

----------

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR UGGMGPUPUURM
Date   Source Headline
12th Jul 20216:15 pmRNSUpdate on timetable for Change of Name
9th Jul 20214:00 pmRNSResult of EGM and Change of Name
7th Jul 20217:00 amRNSFurther Investment in South West Brands Limited
6th Jul 20217:00 amRNSInvestment in cannabis healthcare company- CiiTECH
5th Jul 20217:00 amRNSNew investment - European medical cannabis company
28th Jun 20217:30 amRNSSale of Shares in Portage Biotech
28th Jun 20217:00 amRNSFurther Investment in Little Green Pharma Ltd
22nd Jun 20213:30 pmRNSNotice of EGM & Proposed Change of Name
22nd Jun 20213:00 pmRNSInvestee Company Update: Little Green Pharma Ltd
10th Jun 20217:00 amRNSPurchase of further shares in Little Green Pharma
1st Jun 20217:00 amRNSInvestee Company Update: Yooma Wellness Inc.
28th May 20217:00 amRNSInvestee Company Update: Little Green Pharma
29th Apr 20217:00 amRNSInvestee Company Update: Yooma Wellness
12th Apr 20219:00 amRNSSpecialist Appointed to Strengthen Team
7th Apr 20214:25 pmRNSCompletion of Sale of Investment in EMMAC
1st Apr 20217:00 amRNSNew Investment in Cannabis Cultivator Company
22nd Mar 20213:26 pmRNSInvestee Company Update: Yooma Wellness
18th Mar 20211:55 pmRNSInvestee Company Update: Yooma Wellness Inc.
15th Mar 20217:00 amRNSInvestee Company Update: Leap Gaming
11th Mar 20218:00 amRNSSale of Investments in Kanabo and Cellular Goods
10th Mar 20217:00 amRNSConditional Sale of Investment in EMMAC
8th Mar 202110:21 amRNSInvestee Update: Portage Biotech & Juvenescence
3rd Mar 20217:00 amRNSNew Corporate Presentation
2nd Mar 20212:06 pmRNSInvestee Update: EMMAC Life Sciences and Yooma
1st Mar 20217:00 amRNSNew Investment in Consumer Cannabinoid Company
26th Feb 20214:30 pmRNSHolding(s) in Company
26th Feb 20214:30 pmRNSHolding(s) in Company
26th Feb 20217:15 amRNSInvestor Presentation
26th Feb 20217:00 amRNSCorporate Update
23rd Feb 20214:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20214:35 pmRNSPrice Monitoring Extension
22nd Feb 20218:15 amRNSHolding(s) in Company
18th Feb 20212:05 pmRNSSecond Price Monitoring Extn
18th Feb 20212:00 pmRNSPrice Monitoring Extension
18th Feb 20219:37 amRNSInvestee Company Update: Little Green Pharma Ltd
16th Feb 20212:00 pmRNSPrice Monitoring Extension
16th Feb 202112:20 pmRNSInvestment in Medical Cannabis Company
12th Feb 20217:00 amRNSNew Investment in Medical Cannabis Business
11th Feb 20213:44 pmRNSInvestee Company Update: Portage Biotech Inc.
11th Feb 202110:33 amRNSInvestee Company Update: Yooma Corp.
2nd Feb 202111:09 amRNSInvestee Company Update: Leap Gaming
1st Feb 20217:00 amRNSInvestment - CBD Brand Business, South West Brands
29th Jan 202110:40 amRNSPlacing to raise £2.1 million
26th Jan 20214:12 pmRNSInvestee Company Update: EMMAC Life Sciences
26th Jan 20212:14 pmRNSInvestee Company Update: Yooma Corp.
20th Jan 202112:00 pmRNSInvestee Update: EMMAC Life Sciences & Yooma Corp.
16th Dec 20207:00 amRNSFurther Investment in EMMAC Life Sciences Group
10th Dec 20207:00 amRNSInterim Results
30th Nov 20207:00 amRNSEd McDermott Appointed to the Board of Leap Gaming
24th Nov 20207:00 amRNSInvestee Company Update: Yooma Corp.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.